Personalized Peptides, 3D‑printed.

CraftTab 4-in-1 polypill, a multi-layer 3D-printed tablet, held between two fingers

CraftTab assorted 3D-printed tablets in rows of different shapes, colours and layers

Liquid-filled 3D-printed chewable held in a gloved hand

CraftMake Production Plus pharmaceutical 3D printer from Craft Health

Oral peptides, without the needle

Most peptides must be injected: acid and enzymes break them down in the stomach, and under 1% is absorbed when swallowed. Our printed pill-in-pill carries KPV or BPC-157 past the stomach and releases it in the colon. Since October 2026, HHS lets 503A pharmacies compound six peptides; only KPV and BPC-157 are covered for oral use.

Cutaway render of the CORR3CT pill-in-pill tablet showing the inner pill inside the enteric shell

Colon-targeted KPV and BPC-157

Our patent-pending CORR3CT™ pill-in-pill holds through the stomach and releases the peptide in the colon, where gut disease is. Program 1, launching through telehealth from Q4 2026.

Layered printed gummies (food-grade demonstration sample, not a PharmaTher product)

NAD+ gummy

NAD+ and NMN printed as two layers in one gummy, at the ratio and strength the clinician prescribes. Program 2.

PERSONALIZ3D™ Telehealth

Online visit, printed pill, shipped home. A licensed clinician prescribes, and PD Labs, our U.S. 503A Center of Excellence, prints the pill for that patient.

Compounded products are patient-specific prescriptions and are not FDA-approved. No efficacy claims are made. Launch timing is an internal target. Pill-in-pill image is a render; gummy photo is a food-grade demonstration sample, not a PharmaTher product; the telehealth website screen is an illustrative mockup and PERSONALIZ3D™ is shown as a concept. Oral absorption: Mantaj & Vllasaliu, The Pharmaceutical Journal (2020).

Explore PERSONALIZ3D™ Oral Peptides